SurModics, Inc. (SRDX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Gary R. Maharaj
Employees:
369
9924 W 74TH ST, EDEN PRAIRIE, MN 55344
9525007000

SurModics, Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company offers surface modification coating technologies and components for in vitro diagnostic test kits and microarrays. It operates through two segments: Medical Device and In Vitro Diagnostics. The Medical Device segment engages in contract research and development, as well as manufacturing of balloons catheters used for a variety of interventional cardiology applications. The In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. SurModics was founded in June 1979 and is headquartered in Eden Prairie, MN.

Data derived from most recent annual or quarterly report
Market Cap 624.795 Million Shares Outstanding13.872 Million Avg 30-day Volume 63.189 Thousand
P/E Ratio107.0045 Dividend Yield0.0 EPS0.31
Price to Revenue7.3457 Debt to Equity0.0 EBITDA15.898 Million
Price to Book Value5.5174 Operating Margin8.196399999999999 Enterprise Value713.893 Million
Current Ratio5.927 EPS Growth0.061 Quick Ratio4.78
1 Yr BETA 0.9118 52-week High/Low 62.27 / 37.03 Profit Margin6.8648
Operating Cash Flow Growth85.1281 Altman Z-Score15.6635 Free Cash Flow to Firm 12.002 Million
View SEC Filings from SRDX instead.

View recent insider trading info

Funds Holding SRDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SRDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

15.5 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

5.6 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

OLSON CHARLES W SENIOR VP OF BUS DEV, MED DEV

  • Officer
78,093 2021-11-25 6

STICH JOSEPH J. SVP, HR AND GM, IVD

  • Officer
44,488 2021-11-25 6

ARENS TIMOTHY J. CHIEF FINANCIAL OFFICER

  • Officer
60,693 2021-11-25 4

MAHARAJ GARY R PRESIDENT & CEO

  • Officer
  • Director
143,162 2021-11-25 8

MANDERS JOHN D. CORPORATE CONTROLLER

  • Officer
3,101 2021-11-25 3

SIDES TERI WOODWICK SENIOR VP AND CMO

  • Officer
16,378 2021-11-25 1

DANTZKER DAVID

  • Director
30,821 2021-11-24 7

KALICH RONALD B SR

  • Director
25,339 2021-09-30 6

WEBER GORDON S. SR. VP OF LEGAL, GC AND SEC.

  • Officer
6,955 2021-05-12 1

KNIGHT SUSAN E

  • Director
28,714 2021-02-26 2

BEDOYA JOSE H

  • Director
22,817 2021-02-23 2

SULTANA NUSRATH VP, CLINICAL AFFAIRS

  • Officer
6,566 2021-02-12 1

HEINE LISA WIPPERMAN

  • Director
8,291 2021-02-11 1

MCCORMICK SHAWN

  • Director
9,210 2020-02-13 0

SUTTON GREGG S VP OF RESEARCH AND DEVELOPMENT

  • Officer
25,263 2019-11-27 0

PHILLIPS BRYAN K SVP, GEN COUNSEL & SECRETARY

  • Officer
35,311 2019-11-27 0

GREANEY THOMAS A. COO OF MEDICAL DEVICES

  • Officer
30,013 2019-11-25 0

LAFRENCE ANDREW D. C. VP OF FINANCE & CFO

  • Officer
20,486 2017-11-28 0

SEIBERT AMY E. PRINCIPAL ACCOUNTING OFFICER

  • Officer
1,645 2016-04-28 0

BENSON JOHN W

  • Director
14,199 2015-12-18 0

WARD SCOTT R

  • Director
4,207 2014-12-03 0

FISCHER GERALD B

  • Director
15,557 2014-12-03 0

NELSON TIMOTHY S

  • Director
6,176 2014-12-03 0

LEHMAN MARK A. CORPORATE CONTROLLER

  • Officer
6,957 2014-11-18 0

BUHRMASTER ROBERT C

  • Director
No longer subject to file 2014-02-04 0

BRAINERD MARY K

  • FORMER DIRECTOR
No longer subject to file 2013-12-31 0

STARBOARD VALUE LP

STARBOARD VALUE GP LLC

STARBOARD PRINCIPAL CO LP

STARBOARD PRINCIPAL CO GP LLC

SMITH JEFFREY C

MITCHELL MARK R

FELD PETER A

STARBOARD VALUE & OPPORTUNITY MASTER FUND LTD

  • Director
  • 10% Owner
  • SEE FOOTNOTE 1.SEE FOOTNOTE 1.SEE FOOTNOTE 1.SEE FOOTNOTE 1.SEE FOOTNOTE 1.SEE FOOTNOTE 1.SEE FOOTNOTE 1.SEE FOOTNOTE 1.
No longer subject to file 2012-08-13 0

SMITH JEFFREY C

  • Director
0 2011-11-30 0

MESLOW JOHN A

  • Director
0 2010-11-30 0

KELLER KENNETH H

  • Director
0 2010-11-30 0

ANKENY PHILIP D INTERIM CEO, SENIOR VP & CFO

  • Officer
0 2010-11-30 0

TIPTON ARTHUR J VP, PRES OF PHARMACEUTICALS

  • Officer
0 2010-11-30 0

WEBSTER JAN M VP OF HR

  • Officer
0 2010-11-30 0

RUSCH EUGENE C. VP, MANUFACTURING

  • Officer
0 2010-11-30 0

MECKLER JEFFREY A

  • SEE EXPLANATION OF RESPONSES
0 2010-11-17 0

RAMIUS LLC

C4S & CO LLC

COHEN PETER A

STARK MORGAN B

STRAUSS THOMAS W

SOLOMON JEFFREY M

COWEN GROUP, INC.

RCG HOLDINGS LLC

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
2,088,760 2010-11-16 0

RAMIUS LLC

RAMIUS ADVISORS LLC

RAMIUS VALUE & OPPORTUNITY MASTER FUND LTD

RAMIUS VALUE & OPPORTUNITY ADVISORS LLC

COWEN OVERSEAS INVESTMENT LP

  • 10% Owner
2,088,760 2010-11-16 0

MIDDLETON JOHN C. VP, DRUG DEL, PRODUCT DEV

  • Officer
1,643 2010-07-31 0

ROBEY BRIAN L SR VP, PRODUCT DEVELOPMENT

  • Officer
10,665 2010-05-16 0

BARCLAY BRUCE PRESIDENT & CEO

  • Officer
  • Director
0 2010-02-08 0

DURAN LISE W VP OF RESEARCH

  • Officer
0 2010-02-08 0

ASTRY DOUGLAS P GEN MGR, IN VITRO TECHNOLOGIES

  • Officer
0 2010-02-08 0

ANDERSON ARON B VP & CHIEF SCIENTIFIC OFFICER

  • Officer
0 2010-02-08 0

LOPEZ PAUL A VP, PRESIDENT - OPHTHAMOLOGY

  • Officer
0 2010-02-08 0

SHOUP MICHAEL J VP OF QUAL, REG & CLINICAL

  • Officer
0 2010-02-08 0

MELROSE KENDRICK B

  • Director
0 2008-11-17 0

GINSBERG PETER L VPOF BUS DEVLPMT & STRAT PLAN

  • Officer
0 2008-05-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

OLSON CHARLES W - Officer SENIOR VP OF BUS DEV, MED DEV

2021-11-29 16:31:40 -0500 2021-11-27 F 349 $45.77 d 38,472 direct

ARENS TIMOTHY J. - Officer CHIEF FINANCIAL OFFICER

2021-11-29 16:23:35 -0500 2021-11-27 F 349 $45.77 d 60,693 direct

STICH JOSEPH J. - Officer SVP, HR AND GM, IVD

2021-11-29 16:33:45 -0500 2021-11-27 F 435 $45.77 d 44,488 direct

MANDERS JOHN D. - Officer CORPORATE CONTROLLER

2021-11-29 16:30:40 -0500 2021-11-27 F 45 $45.77 d 3,101 direct

SIDES TERI WOODWICK - Officer SENIOR VP AND CMO

2021-11-29 16:32:48 -0500 2021-11-27 F 271 $45.77 d 16,378 direct

MAHARAJ GARY R - Director - Officer PRESIDENT & CEO

2021-11-29 16:29:16 -0500 2021-11-27 F 1,477 $45.77 d 143,162 direct

SIDES TERI WOODWICK - Officer SENIOR VP AND CMO

2021-11-29 16:32:48 -0500 2021-11-25 F 948 $47.85 d 16,649 direct

MAHARAJ GARY R - Director - Officer PRESIDENT & CEO

2021-11-29 16:29:16 -0500 2021-11-25 F 2,172 $47.85 d 144,639 direct

OLSON CHARLES W - Officer SENIOR VP OF BUS DEV, MED DEV

2021-11-29 16:31:40 -0500 2021-11-25 F 471 $47.85 d 38,821 direct

ARENS TIMOTHY J. - Officer CHIEF FINANCIAL OFFICER

2021-11-29 16:23:35 -0500 2021-11-25 F 544 $47.85 d 61,042 direct

STICH JOSEPH J. - Officer SVP, HR AND GM, IVD

2021-11-29 16:33:45 -0500 2021-11-25 F 586 $47.85 d 44,923 direct

MANDERS JOHN D. - Officer CORPORATE CONTROLLER

2021-11-29 16:30:40 -0500 2021-11-25 F 61 $47.85 d 3,146 direct

DANTZKER DAVID - Director

2021-11-29 16:28:38 -0500 2021-11-24 S 3,475 $47.01 d 30,821 direct

DANTZKER DAVID - Director

2021-11-08 09:55:36 -0500 2021-11-03 F 2,101 $56.56 d 34,296 direct -2.2396 -15.1389 0.0 1 -15.1389 6

DANTZKER DAVID - Director

2021-11-08 09:55:36 -0500 2021-11-03 M 5,576 $21.31 a 36,397 direct -2.2396 -15.1389 0.0 1 -15.1389 6

DANTZKER DAVID - Director

2021-11-08 09:55:36 -0500 2021-11-03 M 5,576 d 0 direct

MAHARAJ GARY R - Director - Officer PRESIDENT & CEO

2021-11-02 17:49:21 -0400 2021-11-01 S 5,800 $54.63 d 147,011 direct yes -1.6266 -9.8303 1.8388 4 -9.8303 6

MAHARAJ GARY R - Director - Officer PRESIDENT & CEO

2021-11-02 17:49:21 -0400 2021-11-01 S 200 $55.25 d 146,811 direct yes -1.6266 -9.8303 1.8388 4 -9.8303 6

MAHARAJ GARY R - Director - Officer PRESIDENT & CEO

2021-10-05 16:01:21 -0400 2021-10-01 S 5,500 $55.97 d 153,311 direct yes 3.032 0.0919 -8.71 5.8434 24 -11.0989 30

MAHARAJ GARY R - Director - Officer PRESIDENT & CEO

2021-10-05 16:01:21 -0400 2021-10-01 S 500 $56.53 d 152,811 direct yes 3.032 0.0919 -8.71 5.8434 24 -11.0989 30

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SURMODICS INC SRDX 2021-11-30 18:15:03 UTC -0.2609 0.3309 550000
SURMODICS INC SRDX 2021-11-30 17:45:03 UTC -0.2609 0.3309 550000
SURMODICS INC SRDX 2021-11-30 17:15:03 UTC -0.2609 0.3309 550000
SURMODICS INC SRDX 2021-11-30 16:45:03 UTC -0.2983 0.3683 550000
SURMODICS INC SRDX 2021-11-30 16:15:02 UTC -0.2983 0.3683 550000
SURMODICS INC SRDX 2021-11-30 15:45:03 UTC -0.2983 0.3683 550000
SURMODICS INC SRDX 2021-11-30 15:15:04 UTC -0.2983 0.3683 550000
SURMODICS INC SRDX 2021-11-30 14:45:02 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-30 14:15:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-30 13:45:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-30 13:15:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-30 12:45:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-29 22:15:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-29 21:45:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-29 21:15:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-29 20:45:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-29 20:15:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-29 19:45:03 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-29 19:15:04 UTC -0.2573 0.3273 550000
SURMODICS INC SRDX 2021-11-29 18:45:03 UTC -0.2508 0.3208 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Index Plus All-Cap Fund SRDX -9.0 shares, $-299.88 2020-03-31 N-PORT

Elevate your investments